|
JP2000078979A
(ja)
|
1998-09-04 |
2000-03-21 |
Taisho Pharmaceut Co Ltd |
テトラヒドロカンナビノール酸シンターゼ遺伝子
|
|
JP2001029082A
(ja)
|
1999-07-22 |
2001-02-06 |
Yukihiro Masayama |
カンナビジオール酸シンターゼをコードするdna
|
|
DE10051427C1
(de)
|
2000-10-17 |
2002-06-13 |
Adam Mueller |
Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
|
|
DK1361864T3
(en)
|
2001-02-14 |
2014-03-03 |
Gw Pharma Ltd |
FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
|
|
US10538373B2
(en)
|
2002-08-14 |
2020-01-21 |
Gw Pharma Limited |
Pharmaceutical formulation
|
|
MXPA05001621A
(es)
|
2002-08-14 |
2005-08-19 |
Gw Pharma Ltd |
Extraccion de cannabinoides farmaceuticamente activos de materiales vegetales.
|
|
GB2393182B
(en)
|
2002-09-23 |
2007-03-14 |
Gw Pharma Ltd |
Method of preparing cannabidiol from plant material
|
|
CN101193884A
(zh)
|
2005-06-13 |
2008-06-04 |
惠氏公司 |
微管蛋白抑制剂和其制备方法
|
|
US8911751B2
(en)
*
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
|
MY148798A
(en)
*
|
2005-11-08 |
2013-05-31 |
Suntory Holdings Ltd |
Method of refining episesamin
|
|
KR101650584B1
(ko)
*
|
2007-08-31 |
2016-08-23 |
디에스엠 아이피 어셋츠 비.브이. |
다중불포화된 지방산 함유 고체 지방 조성물 및 그의 용도 및 생산
|
|
GB2456183A
(en)
|
2008-01-04 |
2009-07-08 |
Gw Pharma Ltd |
Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
|
|
GB2471987B
(en)
|
2008-06-04 |
2012-02-22 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
GB2475183B
(en)
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
GB2478595B
(en)
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Gw伐瑪有限公司 |
使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
EP2500072A1
(en)
*
|
2011-03-15 |
2012-09-19 |
LEK Pharmaceuticals d.d. |
A novel process of residual solvent removal
|
|
CN102351628B
(zh)
*
|
2011-08-10 |
2014-04-16 |
济南卡博唐生物科技有限公司 |
从异己烷和甲醇混合溶剂中除去甲醇的方法
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
US8604062B2
(en)
*
|
2011-10-20 |
2013-12-10 |
Hoffman-La Roche Inc. |
Process for the preparation of isoxazolyl-methoxy nicotinic acids
|
|
GB2504263B
(en)
|
2012-06-08 |
2015-09-16 |
Gw Pharma Ltd |
Synergistic therapies for neuroprotection
|
|
CN102925295A
(zh)
*
|
2012-10-30 |
2013-02-13 |
陕西启源科技发展有限责任公司 |
一种利用餐饮废油生产生物柴油的制备方法
|
|
GB2515312A
(en)
|
2013-06-19 |
2014-12-24 |
Gw Pharma Ltd |
The use of phytocannabinoids in the treatment of ovarian carcinoma
|
|
GB2516814B
(en)
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527591A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
GB2527590A
(en)
|
2014-06-27 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531283A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiols in the treatment of degenerative skeletal muscle diseases
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531280A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
US11034639B2
(en)
*
|
2015-01-22 |
2021-06-15 |
Phytoplant Research S.L. |
Methods of purifying cannabinoids using liquid:liquid chromatography
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2542155B
(en)
|
2015-09-09 |
2018-08-01 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of mental disorders
|
|
GB2542797A
(en)
|
2015-09-29 |
2017-04-05 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of inflammatory skin diseases
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
GB2551985B
(en)
|
2016-07-01 |
2019-01-30 |
Gw Res Ltd |
Novel formulation
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
US10155176B1
(en)
|
2016-11-03 |
2018-12-18 |
Healer, LLC |
Process for the production of a concentrated cannabinoid product
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
CN110678481B
(zh)
|
2017-03-16 |
2023-10-31 |
伊沃芙生物制品公司 |
用于纯化白蛋白的方法
|
|
CN107011125B
(zh)
*
|
2017-05-06 |
2020-07-28 |
云南汉木森生物科技有限责任公司 |
一种富集大麻二酚的方法
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
US9919241B1
(en)
|
2017-06-27 |
2018-03-20 |
Entheo Gardens Inc |
Extraction method
|
|
US10189762B1
(en)
|
2017-07-07 |
2019-01-29 |
Orochem Technologies, Inc. |
Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
|
|
IT201700085508A1
(it)
|
2017-07-26 |
2019-01-26 |
Inalco S R L |
Metodo per la produzione di cannabinoidi da varietà di canapa industriale
|
|
GB201715919D0
(en)
|
2017-09-29 |
2017-11-15 |
Gw Res Ltd |
use of cannabinoids in the treatment of epilepsy
|
|
GB2568471B
(en)
|
2017-11-15 |
2022-04-13 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2572125B
(en)
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572126B
(en)
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572737A
(en)
|
2018-01-24 |
2019-10-16 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
WO2019195752A1
(en)
*
|
2018-04-05 |
2019-10-10 |
Canopy Holdings, LLC |
Hemp powder
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
WO2020028198A1
(en)
*
|
2018-08-03 |
2020-02-06 |
Biomass Oil Separation Solutions, Llc |
Processes and apparatus for extraction of substances and enriched extracts from plant material
|
|
GB2579179A
(en)
|
2018-11-21 |
2020-06-17 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
CA3138732A1
(en)
|
2018-11-30 |
2020-06-04 |
Canopy Growth Corporation |
Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
|
|
GB2580881A
(en)
|
2018-11-30 |
2020-08-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US10413845B1
(en)
*
|
2018-12-14 |
2019-09-17 |
Socati Technologies |
Processes for solvent extraction of cannabinoids, terpenes and flavonoids from biomass
|
|
US10414709B1
(en)
*
|
2018-12-14 |
2019-09-17 |
Socati Technologies |
Processes for solvent extraction of cannabinoids, terpenes and flavonoids from biomass
|
|
GB2580653A
(en)
|
2019-01-21 |
2020-07-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of comorbidities associated with epilepsy
|
|
GB2581517A
(en)
|
2019-02-22 |
2020-08-26 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2581987B
(en)
|
2019-03-06 |
2021-11-17 |
Gw Res Ltd |
Use of cannabidiol in combination with antibiotics
|
|
GB2584140A
(en)
|
2019-05-23 |
2020-11-25 |
Gw Res Ltd |
Use of cannabidiol in the treatment of epileptic spasms
|
|
GB2584341B
(en)
|
2019-05-31 |
2023-03-01 |
Gw Res Ltd |
Cannabinoid formulations
|
|
CN110304994B
(zh)
*
|
2019-07-01 |
2022-04-01 |
吴平 |
一种从工业大麻中提取高纯度大麻二酚的方法
|
|
GB201910389D0
(en)
|
2019-07-19 |
2019-09-04 |
Gw Pharma Ltd |
Novel compounds, methods for their manufacture, and uses thereof
|
|
GB2586026A
(en)
|
2019-07-29 |
2021-02-03 |
Gw Res Ltd |
Use of cannabidol in the treatment of Dravet syndrome
|
|
GB2588576A
(en)
|
2019-08-27 |
2021-05-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease
|
|
GB2588461A
(en)
|
2019-10-25 |
2021-04-28 |
Gw Res Ltd |
Use of cannabidiol preparations in the treatment of absence epilepsy
|
|
GB2588457B
(en)
|
2019-10-25 |
2022-12-21 |
Gw Res Ltd |
Cannabinoid compound
|
|
GB201916846D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916849D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916974D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannabidol-type cannabinoid compound
|
|
GB201916977D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannibidol-type cannabinoid compound
|
|
GB201918846D0
(en)
|
2019-12-19 |
2020-02-05 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
US20210370198A1
(en)
*
|
2020-05-29 |
2021-12-02 |
Chemtor, Lp |
Purification and extraction of cannabinoids
|
|
US20220087951A1
(en)
|
2020-09-18 |
2022-03-24 |
GW Research Limited |
Use of cannabinoids in the treatment of epilepsy
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
US11815187B2
(en)
|
2022-01-26 |
2023-11-14 |
Maag Germany Gmbh |
3-port valve
|